State Street’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

State Street’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-77,578	Closed	-$3.02M	–	3821
2017 Q3	$3.02M	Buy	77,578 +19,200	+33%	+$706K	﹤0.01%	3030
2017 Q2	$1.75M	Buy	58,378 +11,163	+24%	+$289K	﹤0.01%	3191
2017 Q1	$1.25M	Sell	47,215 -18,724	-28%	-$464K	﹤0.01%	3219
2016 Q4	$1.45M	Buy	65,939 +34,330	+109%	+$642K	﹤0.01%	3203
2016 Q3	$584K	Buy	31,609 +11,900	+60%	+$206K	﹤0.01%	3274
2016 Q2	$320K	Buy	+19,709	New	+$332K	﹤0.01%	3459

Other funds holding NDRM

VOAM

Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

State Street's NDRM Position: Q4 2017 in Review

State Street sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 77,578 shares — an estimated $3.02M sold.

State Street first reported a position in NDRM in Q2 2016 and held it in 6 quarters. The position peaked at $3.02M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

State Street reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
State Street sold 77,578 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $3.02M.
State Street first reported a position in NeuroDerm Ltd. Ordinary Shares in Q2 2016 and held it in 6 quarters.
State Street's NeuroDerm Ltd. Ordinary Shares position peaked at $3.02M in Q3 2017.
5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on State Street's 13F filing for Q4 2017, filed 14 Feb 2018.